SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-127602
Filing Date
2018-04-24
Accepted
2018-04-24 06:21:03
Documents
3
Effectiveness Date
2018-04-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A d481315ddefa14a.htm DEFA14A 18644
2 GRAPHIC g481315img1.jpg GRAPHIC 329103
3 GRAPHIC g481315img2.jpg GRAPHIC 297351
  Complete submission text file 0001193125-18-127602.txt   872497
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-30171 | Film No.: 18770026
SIC: 2836 Biological Products, (No Diagnostic Substances)